At IMARC, we go beyond data – we deliver actionable intelligence tailored to the pharmaceutical industry’s unique complexities. From drug development pipelines and market sizing to regulatory trends and competitor benchmarking, our insights help pharma stakeholders make informed, confident decisions.
IMARC delivers data-rich epidemiology reports using trusted databases, peer-reviewed research, and in-house modeling.
Our reports cover 7MM, emerging markets, and key regions with localized disease prevalence and incidence data.
IMARC provides historical data and 10–15 year forecasts to track disease trends and guide decisions.
Data is vetted by disease area specialists and key opinion leaders, making it highly credible and aligned with clinical reality.
Detailed by age, gender, severity, and more—making data actionable for clinical, marketing, and forecasting teams.
IMARC is a trusted partner for leading pharma, biotech, and consulting firms, making its epidemiology data a reliable, proven choice.